---
title: "New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare | GH Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279039962.md"
description: "New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare | GH Stock News"
datetime: "2026-03-13T04:05:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279039962.md)
  - [en](https://longbridge.com/en/news/279039962.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279039962.md)
---

# New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare | GH Stock News

New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare | GH Stock News

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [GH.US](https://longbridge.com/en/quote/GH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)

## Related News & Research

- [Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst](https://longbridge.com/en/news/282733296.md)
- [Revolution Medicines' experimental cancer pill helps improve survival in late-stage study](https://longbridge.com/en/news/282540793.md)
- [Natera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion](https://longbridge.com/en/news/282586000.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [Should Positive Elsunersen Data And Relutrigine Priority Review Shift the Narrative for Praxis (PRAX) Investors?](https://longbridge.com/en/news/282419526.md)